Europe Pharmaceutical Contract Manufacturing Market Size to Reach $108.1 Billion by 2035

European pharmaceutical contract manufacturing market size reached $47.9 billion in 2025 and is projected to expand to $108.1 billion by 2035, growing at a CAGR of 8.5% during the forecast period (2026–2035). Market growth is supported by rising outsourcing of drug production, increased R&D investments, and demand for specialized manufacturing services.

Key Market Drivers

• Increasing outsourcing of drug production to contract manufacturers.
• Rising pharmaceutical R&D expenditure across Europe.
• Growing demand for sterile and complex formulation services.
• Expansion of biologics and advanced therapy pipelines.
• Increasing focus on regulatory compliance and quality standards.

Browse the full report description of “European Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Manufacturing Process Type (Sterile Manufacturing, and Non-Sterile Manufacturing) By Product Type (OTC, API, Finished Dosage Formulation, and Others) By Route of Administration (Oral, Inhaled, Parenteral, and Others) By Service (R&D, Manufacturing, and Non-Clinical) Forecast 2026-2035” of https://www.omrglobal.com/industry-reports/european-pharmaceutical-contract-manufacturing-market

Regional Analysis

European pharmaceutical contract manufacturing market encompasses Western and Eastern Europe, where regulatory frameworks and manufacturing capacities significantly influence growth. In Germany, stringent quality regulations and established pharmaceutical infrastructure support sustained contract manufacturing operations. The UK continues to attract contract manufacturing activity due to its robust clinical research environment and established biotech sector, despite post?Brexit regulatory adjustments. In Russia, pharmaceutical manufacturing expansion is influenced by import substitution policies and investment incentives aimed at bolstering domestic production capacity. Across Europe, harmonization of regulatory standards under the European Medicines Agency framework facilitates cross?border manufacturing collaborations and quality assurance in outsourced production.

Competitive Landscape

Key companies operating in the European pharmaceutical contract manufacturing market include Lonza Group, Recipharm, Catalent, Fareva, Bachem, Evonik Industries, Siegfried Holding, and Boehringer Ingelheim BioXcellence. These companies are operating in sterile and non?sterile manufacturing, formulation development, and biologics production services. They focus on expanding capacity, enhancing technical expertise, and supporting regulatory compliance to meet evolving pharmaceutical outsourcing needs.

Recent Market Developments

• In March 2025, Recipharm reported increased revenue and strategic milestones for 2024, including enhanced biologics and sterile production capabilities. The results point to ongoing expansion of contract manufacturing capacity in Europe.
• In October 2025, Lonza Group reaffirmed its CDMO contract outlook It expects continued contract activity across technologies and sites.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By manufacturing process type
  • By product type
  • By route of administration
  • By service
• Region Covered-
  • Europe

Competitive Landscape- Lonza Group, Recipharm, Catalent, Fareva, Bachem, Evonik Industries, Siegfried Holding, and Boehringer Ingelheim BioXcellence.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Europe Pharmaceutical Contract Manufacturing Market Report Segment

By manufacturing process type

• Sterile manufacturing
• Non-sterile manufacturing

By product type

• OTC
• API
• Finished dosage formulation
• Others

By route of administration

• Oral
• Inhaled
• Parenteral
• Others

By service

• R&D
• Manufacturing
• Non-clinical

Europe Pharmaceutical Contract Manufacturing Market Report Segment by Region

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/european-pharmaceutical-contract-manufacturing-market